Suppr超能文献

质子泵抑制剂治疗的骨相关影响:一项伞状综述。

Osseous implications of proton pump inhibitor therapy: An umbrella review.

作者信息

Alanazi Abdullah S, Almutairi Hadiah, Gupta Jeetendra Kumar, Mohanty Dibyalochan, Rath Deepankar, AlOdan Ali A, Mahal Ahmed, Khatib Mahalaqua Nazli, Gaidhane Shilpa, Zahiruddin Quazi Syed, Rustagi Sarvesh, Satapathy Prakasini, Serhan Hashem Abu

机构信息

Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Al-Jouf, Saudi Arabia.

Department of Pharmacy Practice, College of Pharmacy, University of Hafr Albatin, Saudi Arabia.

出版信息

Bone Rep. 2024 Feb 1;20:101741. doi: 10.1016/j.bonr.2024.101741. eCollection 2024 Mar.

Abstract

BACKGROUND

Proton pump inhibitors (PPIs) are among the most commonly prescribed medications worldwide for acid-related disorders. While their short-term efficacy and safety are well-established, concerns regarding their long-term effects on bone health have emerged. This umbrella review aimed to synthesize the available findings on the associations between PPI use and bone metabolism outcomes.

METHODS

An electronic search was conducted using PubMed, Web of Science, Embase, and the Cochrane Database up to September 16, 2023. Systematic reviews and meta-analyses of randomized controlled trials (RCTs) and observational studies that evaluated the relationship between PPIs and bone metabolism outcomes were included. Data extraction, quality appraisal, and synthesis were performed in line with the Joanna Briggs Institute and PRISMA guidelines. The strength of the evidence was graded using the GRADE criteria. Statistical analysis was performed in R version 4.3.

RESULTS

Out of 299 records, 27 studies met the inclusion criteria. The evidence indicated a statistically significant increased risk of fractures, notably hip, spine, and wrist fractures, in PPI users. PPI use was associated with changes in Bone Mineral Density (BMD) across various bones, though the clinical relevance of these changes remains uncertain. Furthermore, PPI-induced hypomagnesemia, which can influence bone health, was identified. A notable finding was the increased risk of dental implant failures in PPI users. However, the certainty of most of the evidence ranged from very low to low based on GRADE criteria.

CONCLUSION

The long-term use of PPIs may be associated with adverse bone health outcomes, including increased fracture risk, alterations in BMD, hypomagnesemia, and dental implant failure. While these findings highlight potential concerns for long-term PPI users, the current evidence's low certainty underscores the need for robust, high-quality research to clarify these associations.

摘要

背景

质子泵抑制剂(PPIs)是全球范围内治疗酸相关疾病最常用的药物之一。虽然其短期疗效和安全性已得到充分证实,但有关其对骨骼健康长期影响的担忧已经出现。本系统综述旨在综合关于使用PPIs与骨代谢结果之间关联的现有研究结果。

方法

截至2023年9月16日,使用PubMed、科学网、Embase和Cochrane数据库进行了电子检索。纳入了评估PPIs与骨代谢结果之间关系的随机对照试验(RCTs)和观察性研究的系统综述和荟萃分析。根据乔安娜·布里格斯研究所和PRISMA指南进行数据提取、质量评估和综合分析。使用GRADE标准对证据强度进行分级。在R 4.3版本中进行统计分析。

结果

在299条记录中,27项研究符合纳入标准。证据表明,使用PPIs的患者骨折风险在统计学上显著增加,尤其是髋部、脊柱和腕部骨折。使用PPIs与不同骨骼的骨矿物质密度(BMD)变化有关,尽管这些变化的临床相关性仍不确定。此外,还发现了PPIs引起的低镁血症,这可能会影响骨骼健康。一个值得注意的发现是,使用PPIs的患者牙种植失败风险增加。然而,根据GRADE标准,大多数证据的确定性从极低到低不等。

结论

长期使用PPIs可能与不良骨骼健康结果相关,包括骨折风险增加、BMD改变、低镁血症和牙种植失败。虽然这些发现凸显了长期使用PPIs患者的潜在担忧,但目前证据的低确定性强调需要进行有力的高质量研究来阐明这些关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验